Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia.

Autor: Naji, Nour Sabiha¹ (AUTHOR) nnaji1@jh.edu, Sathish, Mrudula² (AUTHOR) mrudula.sathish@einsteinmed.edu, Karantanos, Theodoros¹ (AUTHOR) tkarant1@jhmi.edu

Publikováno v: Cancers. Dec2024, Vol. 16 Issue 23, p3974. 19p.

A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia.

Autor: Short NJ; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cortes JE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thomas DA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rytting ME; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pediatrics-Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kebriaei P; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bivins C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCue D; Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Richie MA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2018 Aug; Vol. 182 (3), pp. 442-444. Date of Electronic Publication: 2017 Jun 14.

Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.

Autor: Jabbour E; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Guastad Daver N; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Short NJ; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Huang X; Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Chen HC; Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Maiti A; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Ravandi F; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Cortes J; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Abi Aad S; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Garcia-Manero G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Estrov Z; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Kadia T; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., O'Brien S; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Dabaja B; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Bueso-Ramos C; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Strati P; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Bivins C; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Pierce S; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030., Kantarjian H; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030.

Publikováno v: American journal of hematology [Am J Hematol] 2017 Sep; Vol. 92 (9), pp. 924-928. Date of Electronic Publication: 2017 Jul 19.

Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.

Autor: Hu, Yamei^1,2 (AUTHOR), Dong, Zigang^1,3,4 (AUTHOR) zgdong@hci-cn.org, Liu, Kangdong^1,3,4,5,6 (AUTHOR) kdliu@zzu.edu.cn

Publikováno v: Journal of Experimental & Clinical Cancer Research (17569966). 1/20/2024, Vol. 43 Issue 1, p1-29. 29p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.